Telomir Pharmaceuticals, Inc. Common Stock (TELO)
Telomir Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing products that target aging and age-related diseases through telomere biology. The company aims to leverage telomere science to create innovative therapies for extending healthspan and lifespan.
Company News
U.S. stock futures fell on Tuesday, with market attention focused on potential Federal Reserve rate cuts and ongoing government shutdown. Key companies like AMD and Trilogy Metals saw significant stock movements due to strategic developments.
TAMPA, Fla., July 02, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq: TELO) (“Telomir” or the “Company”), a pre-clinical-stage pharmaceutical company focused on the development and commercialization of Telomir-1 as the first novel small molecule to lengthen the DNA’s protective telomere caps as a potential treatment fo...